Robert Goldfarb - Ruane, Cunniff & Goldfarb
Holding/activity history for Elevance Health Inc. (ELV)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,387,968 | 6.74 | Reduce 2.43% | 0.19 | $292.75 | $406,327,632 | SEC |
| 2025 Q4 | 1,422,506 | 7.79 | Reduce 1.78% | 0.14 | $350.55 | $498,659,478 | SEC |
| 2025 Q3 | 1,448,283 | 7.75 | Add 32.18% | 1.89 | $323.12 | $467,969,203 | SEC |
| 2025 Q2 | 1,095,655 | 7.31 | Reduce 2.43% | 0.22 | $388.96 | $426,165,969 | SEC |
| 2025 Q1 | 1,122,920 | 8.87 | Reduce 1.84% | 0.13 | $434.96 | $488,425,283 | SEC |
| 2024 Q4 | 1,143,953 | 7.16 | Add 13.88% | 0.87 | $368.90 | $422,004,262 | SEC |
| 2024 Q3 | 1,004,533 | 8.17 | Reduce 1.91% | 0.17 | $520.00 | $522,357,160 | SEC |
| 2024 Q2 | 1,024,071 | 8.65 | Reduce 4.71% | 0.41 | $541.86 | $554,903,112 | SEC |
| 2024 Q1 | 1,074,685 | 8.65 | Reduce 4.19% | 0.35 | $518.54 | $557,267,160 | SEC |
| 2023 Q4 | 1,121,643 | 8.45 | Reduce 2.48% | 0.21 | $471.56 | $528,921,973 | SEC |
| 2023 Q3 | 1,150,221 | 8.31 | Add 9.69% | 0.73 | $435.42 | $500,829,228 | SEC |
| 2023 Q2 | 1,048,648 | 7.35 | Add 29.92% | 1.69 | $444.29 | $465,903,820 | SEC |
| 2023 Q1 | 807,124 | 6.06 | Reduce 2.35% | 0.16 | $459.81 | $371,123,687 | SEC |
| 2022 Q4 | 826,523 | 6.62 | Reduce 16.33% | 1.09 | $512.97 | $423,981,503 | SEC |
| 2022 Q3 | 987,857 | 6.67 | Reduce 2.58% | 0.16 | $454.24 | $448,724,000 | SEC |
| 2022 Q2 | 1,013,987 | 6.38 | Reduce 42.30% | 3.60 | $482.58 | $489,330,000 | SEC |
| 2022 Q1 | 1,757,428 | 8.50 | Reduce 0.71% | 0.05 | $491.22 | $863,284,000 | SEC |
| 2021 Q4 | 1,770,040 | 7.01 | Reduce 2.82% | 0.17 | $463.54 | $820,484,000 | SEC |
| 2021 Q3 | 1,821,413 | 6.10 | Reduce 1.22% | 0.08 | $372.80 | $679,023,000 | SEC |
| 2021 Q2 | 1,844,001 | 6.24 | Add 57.36% | 2.27 | $381.80 | $704,040,000 | SEC |
| 2021 Q1 | 1,171,845 | 3.96 | Buy | 3.96 | $358.95 | $420,634,000 | SEC |